Risk Factors for Mortality in Carbapenem-Resistant Klebsiella pneumoniae Infections Treated with Ceftazidime–Avibactam: A Real-Life Cohort Study
Infection & Chemotherapy · 2026 · 58
DOI: 10.3947/ic.2026.0026 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Infection & Chemotherapy, 2026. Verfasst von Esma Eryılmaz Eren und 7 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Eren, E. E., Güleyyüpoğlu, M. D., Kefkir, A., Deveci, K., Tok, T., Toker, A. K., Kayabaş, Ü., & Çelik, İ. (2026). Risk Factors for Mortality in Carbapenem-Resistant Klebsiella pneumoniae Infections Treated with Ceftazidime–Avibactam: A Real-Life Cohort Study. Infection & Chemotherapy, 58. https://doi.org/10.3947/ic.2026.0026
Vancouver
Eren EE, Güleyyüpoğlu MD, Kefkir A, Deveci K, Tok T, Toker AK, et al. Risk Factors for Mortality in Carbapenem-Resistant Klebsiella pneumoniae Infections Treated with Ceftazidime–Avibactam: A Real-Life Cohort Study. Infection & Chemotherapy. 2026;58. doi:10.3947/ic.2026.0026
BibTeX
@article{Eren2026,
author = {Eren, Esma Eryılmaz and Güleyyüpoğlu, Merve Dağdelen and Kefkir, Ayşenur and Deveci, Kamil and Tok, Tuğba and Toker, Ayşin Kılınç and Kayabaş, Üner and Çelik, İlhami},
title = {Risk Factors for Mortality in Carbapenem-Resistant Klebsiella pneumoniae Infections Treated with Ceftazidime–Avibactam: A Real-Life Cohort Study},
journal = {Infection & Chemotherapy},
year = {2026},
volume = {58},
doi = {10.3947/ic.2026.0026}
}
EUVIMED